Simulations Plus Acquires Cognigen

Lancaster-based Simulations Plus, which develops simulation and modeling software for the pharmaceuticals industry, said late Wednesday night that it has acquired Cognigen Corporation, a provider of clinical trial data analysis software. Simulations Plus said it will pay $7M for Cognigen, split between $2.8M in cash and $4.2M in stock. Cognigen will become a wholly owned subsidiary of Simulations Plus, and continue to operate under its own name. Simulations Plus was advised by Excel Partners in the deal.